Below is the speaker list for 2010′s 7th Anti-infectives Partnering and Deal-making Summit. To view the speaker list for 2011′s 8th Anti-infectives Partnering and Deal-making summit information, which is taking place on November 7-8, 2011 in Boston, MA, please click here.

Professor, Molecular Biology & Microbiology and Medicine
Director, Center for Adaptation Genetics and Drug Resistance
Tufts University;
President
Alliance for the Prudent Use of Antibiotics;
Chief Scientific Officer and Co-Founder
Paratek Pharmaceuticals

Neil S. Ryder, Ph.D. - Featured Speaker
Executive Director, Infectious Diseases
Novartis

Danielle Drayton, Ph.D. - Featured Speaker
Therapeutic Area Director, Infectious Diseases & DecisionBase
Decision Resources

Michael Chaparian
President and CEO
SelectX Pharmaceuticals, Inc.

Mike Dudley
Chief Scientific Officer
Senior Vice President, Research & Development
Mpex Pharmaceuticals, Inc.

Roger Echols
Principal
Infectious Disease Drug Development Consulting, LLC

Mike Fuller
Partner
Knobbe Martens Olson & Bear

Michael Goldblatt
President and CEO
Functional Genetics

Robert Guidos
Vice President, Public Policy & Govt. Relations
Infectious Diseases Society of America IDSA

Barry Hafkin
Chief Financial Officer
Affinium Pharmaceuticals

Vincent Hernandez
Director, Medicinal Chemistry
Anacor Pharmaceuticals

Robert Jacks, MS, MBA
Business Development Advisor
Tobira Therapeutics

Laurenz Kellenberger, Ph.D.
Chief Scientific Officer
Basilea Pharmaceutica International

Nicholas Landekic
President & CEO
PolyMedix

Casey Logan
Vice President, Corporate Development & Strategic Planning
Anadys Pharmaceuticals

Jarrod Longcor
Senior Director, Business Development
Rib-X Pharmaceuticals

Alexandra Makarova, M.D., Ph.D.
Analyst, Infectious Diseases
Decision Resources

Dennis Molnar
Vice President, Corporate Development
Paratek Pharmaceuticals

Brian Noonan
Senior Director, Director of Bioscience
Astrazeneca

Rodger Novak, M.D.
Chief Operating Officer
Nabriva Therapeutics

Antonio Perez, M.D.
Senior Advisor Clinical Development
Kenta Biotech

Eddie Power
Global Medical Director
Cubist

John Quinn
Senior Advisor, Antibacterial
Pfizer

Jane Ryan, Ph.D.
Vice President, Product Development
Biota

Karen Joy Shaw, Ph.D.
Senior Vice President, Biology
Trius Therapeutics

Paul A. Stewart
Director, Global Business Development
Eli Lilly and Company - Elanco Animal Health Division

Thomas Storey
Manager, External R&ampD Affairs
Amgen

Joyce Sutcliffe, Ph.D.
Senior Vice President, Biology
Tetraphase Pharmaceuticals

Ursula Theuretzbacher, Ph.D.
Principal
Center for Anti-Infective Agents CEFAIA

Glenn S. Tillotson, Ph.D., FRSM, FCCP
Head of Medical Affairs
Viropharma